Immunohistochemistry (IHC) Market Research Report - Key Trends & Forecasts


Posted January 4, 2024 by delvens123

The global immunohistochemistry market is projected to reach USD 3.3 billion by 2026 from USD 2.3 billion in 2021, at a CAGR of 7.7% during the forecast period of 2021 to 2028.

 
Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End user (Hospitals, Diangostic labs, Academia), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
Immunohistochemistry (IHC) Market Overview
The global immunohistochemistry market is projected to reach USD 3.3 billion by 2026 from USD 2.3 billion in 2021, at a CAGR of 7.7% during the forecast period of 2021 to 2028.
A laboratory method that uses antibodies to check for certain antigens (markers) in a sample of tissue. The antibodies are usually linked to an enzyme or a fluorescent dye. IHC has become a crucial technique and is widely applied in the diagnosis of several chronic diseases such as cancer, infectious diseases, and cardiovascular diseases (CVDs).
The rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, technological advancements in IHC, and availability of reimbursements for IHC tests are some of the factors that have supported long-term expansion for Immunohistochemistry (IHC) Market.
Get a Sample Copy of the Immunohistochemistry (IHC) Market Research Report: https://www.delvens.com/get-free-sample/immunohistochemistry-market
Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Within a few weeks of research, companies started coming up with drugs and treatments to treat the infection. There has been a tremendous amount of effort put into developing new treatments and vaccines to cure the infection.
Immunohistochemistry (IHC) Market Regional Analysis
North America was the largest regional market for immunohistochemistry market in 2020. APAC is expected to register the fastest growth rate during the forecast period owing to several factors, including increasing disposable income, rising healthcare spending, growing demand for quality medical care, and increasing investments by pharmaceutical and biopharmaceutical companies.
Immunohistochemistry (IHC) Market Competitive Landscape
Key Players
• F. Hoffman-La Roche AG
• Danaher Corporation
• Agilent Technologies, Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Abcam plc
• Becton, Dickinson and Company
• PerkinElmer, Inc.
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.
• PHC Holdings Corporation
• Cell Signaling Technology, Inc.
• Bio SB, Inc.
• Miltenyi Biotec
• CANDOR Bioscience GmbH
• Sakura Finetek Japan Co., Ltd.
• Eagle Biosciences, Inc.
• Biocare Medical, LLC
• Elabscience, Inc.
• Biogenex Laboratories
• Diagnostic Biosystems, Inc.
• BioVision Inc.
• Rockland Immunochemicals, Inc.
• Genemed Biotechnologies, Inc.
Inquire before you purchase to increase your business' revenue: https://www.delvens.com/Inquire-before-buying/immunohistochemistry-market
Immunohistochemistry (IHC) Market Recent Developments
• In August 2021, Roche received FDA approval for VENTANA MMR RxDx companion diagnostic test based on immunohistochemistry for solid tumors that are deficient in the MMR pathway. The test identifies patients eligible for GSK’s anti-PD1 immunotherapy, JEMPERLI.
• In August 2021, Agilent received a CE-IVD mark in Europe for its PD-L1 IHC 22C3 pharmDx assay for the identification of oesophageal cancer patients for treatment with KEYTRUDA.
Reasons to Acquire in the Immunohistochemistry (IHC) Market
• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
• Gain authentic and granular data access for Immunohistochemistry (IHC) Market so as to understand the trends and the factors involved behind changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns
Direct Purchase of Immunohistochemistry (IHC) Market Report Research Report: https://www.delvens.com/checkout/immunohistochemistry-market
Frequently Asked Questions
What are the years considered to study Immunohistochemistry (IHC) Market?
What is the compound annual growth rate (CAGR) of the Immunohistochemistry (IHC) Market?
Which region holds the largest market share in Immunohistochemistry (IHC) Market?
Which region is the fastest growing in Immunohistochemistry (IHC) Market?
Who are the major players in Immunohistochemistry (IHC) Market?
Browse Related Reports:
Pendred Syndrome (PS) Market – Trends Forecast Till 2030
Pendred Syndrome (PS) Market by Treatment (Cochlear Implant, Hearing Aids, and Radioactive Iodine) Route of Administration (Oral, Implantation), Diagnosis (Genetic Testing, Perchlorate Washout Test, and Others), End- Users (Hospitals, Homecare, Specialty Clinics, Otolaryngologist, and Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Pain Relief Gel Market – Trends Forecast Till 2030
Global Pain Relief Gel Market, By Therapeutic Class (Non-Opioids, Opioids), Type (Prescription Pain Relief, Over-the-Counter Pain Relief), Distribution Channel (Pharmacies & Drug Stores, e-Commerce, Retail & Grocery Stores) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Non-Small Cell Lung Cancer (NSCLC) Market – Trends Forecast Till 2030
Non-Small Cell Lung Cancer (NSCLC) Market, by Type (Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma, Others), by Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy), by Distribution Channel (Hospital Pharmacy, Drug Store and Retail Pharmacy, Online Pharmacy) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Delvens
Country Germany
Categories Business , Research
Last Updated January 4, 2024